PATENT CLAIM ANALYSIS

Application Number: 16032044
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "054000"]

Abstract:
The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.

Claim (Index 77):
The ophthalmic pharmaceutical composition of  claim 71 , wherein the ophthalmic pharmaceutical composition is effective for correction of presbyopia for up to 24 hours.

Metadata:
- Claim Count in Document: 200.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15680967', '14860777', '14860770', '15235431', '14717073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618906468541606
- 35 USC 102 Novelty (BERT): 0.5820991706264956
- Combined Prediction Score: 0.7439114992313941
- Mean Citation Score: 270.06201400000003
- Max Citation Score: 493.07025
- Similarity Product: 408.7969093640149

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test